American Laboratory Products Co., an in vitro diagnostics company, has merged with GeneProof, a molecular diagnostics company. The combined company is majority-owned by Ampersand Capital Partners, which invested in American Laboratory Products in 2020.

American Laboratory Products Company is a producer of novel immunodiagnostic reagents for specialty testing laboratories. GeneProof offers a range of in vitro molecular diagnostic services, primarily focused on infectious diseases and genetic mutations. The combined company creates a provider in the diagnostic products market, with broad capabilities spanning real-time PCR testing and automated laboratory instrumentation services.

“ALPCO and GeneProof have both earned great reputations in their respective markets, ALPCO in immunodiagnostics and GeneProof in molecular diagnostics,” said Sean Conley, CEO of ALPCO. “The combination of the two companies transforms both organizations into a more complete solutions provider and aligns well with ALPCO’s strategy of investing in proprietary automated platforms.”